4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-071965
Chief Financial Officer gave up 9,346 shares (to pay taxes)
- Chief Financial Officer acquired 18,850 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellemin Jean-Marc Chief Financial Officer | 2022-06-14 | Option exercise | +18,850 | 18,850 | D: show line 1 in the form | ||
| Bellemin Jean-Marc Chief Financial Officer | 2022-06-14 | Shares withheld for taxes | −9,346 | $7.73 | $72,245 | 9,504 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellemin Jean-Marc Chief Financial Officer | 2022-06-14 | Grant or award · Restricted Stock Units | +18,850 | 18,850 | D: show line 3 in the form |
Loading xslF345X03/tm2218629-2_4seq1.xml…